DailyTickers

FSLR — First Solar, Inc.

NASDAQ · Technology · August 28, 2026
$210.41 +0.14% Wait; trend is damaged Solar Score 58 C+
$22.61B
Market Cap
1.5M
Volume
N/A
Fwd P/E
1.746
Beta
N/A
52W Range
11.9%
Short Interest
$274.44
Analyst Target
8.8x
EV/EBITDA
FSLR Chart
Click to enlarge

Verdict Express

C+ Neutral Moderate confidence

First Solar, Inc., a solar technology company, provides photovoltaic (PV) solar energy solutions in the United States, France, India, Chile, and internationally. The company manufactures and sells PV solar modules with thin film semiconductor technology that provides conventional crystalline silicon PV solar modules. Wait; trend is damaged. Wait state: Reclaim $213.20 and VWAP.

Why Buy

  • Revenue growth: -3.7%; earnings growth: 23.3%
  • Cash $1.73B versus debt $194.0M
  • Defined confirmation: Reclaim $213.20 and VWAP

Why Avoid

  • Wait state: Reclaim $213.20 and VWAP.
  • First-target reward/risk at confirmation: 0.84R
  • Series 7 defects carry an estimated $40M-$65M loss range.

Business Overview

First Solar, Inc., a solar technology company, provides photovoltaic (PV) solar energy solutions in the United States, France, India, Chile, and internationally. The company manufactures and sells PV solar modules with thin film semiconductor technology that provides conventional crystalline silicon PV solar modules. It also designs, manufactures, and sells cadmium telluride solar modules that convert sunlight into electricity. The company serves system developers, independent power producers, utilities, commercial and industrial companies, large corporate energy buyers, and other system owners and operators. The company was formerly known as First Solar Holdings, Inc. and changed its name to First Solar, Inc. in 2006. First Solar, Inc. was founded in 1999 and is headquartered in Phoenix, Arizona.

Recent News

2026-08-27
First Solar upgraded, Celsius downgraded: Wall Street's top analyst calls positive
Potentially supportive for expectations; verify the magnitude in the primary release before acting.
The Fly
2026-08-27
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, Choice Hotels International, DigitalOcean Holdings, First Solar, LTC Properties, Okta, Regions Financial, Synopsys, and More neutral
Context only; no trade conclusion is drawn from this headline.
24/7 Wall St.
2026-08-27
BMO Capital Upgrades First Solar to Outperform From Market Perform, $265 Price Target positive
Potentially supportive for expectations; verify the magnitude in the primary release before acting.
MT Newswires
2026-08-27
Why Are ENPH, FSLR, ARRY, SEDG Stocks Rising Overnight? neutral
Context only; no trade conclusion is drawn from this headline.
Stocktwits

Fundamentals

MetricValueSignal
Revenue (TTM)$5.38B-3.7% YoY
EBITDA$2.39B8.8x EV/EBITDA
Gross Margin44.0%Reported
Operating Margin42.6%Profitable
Net Margin32.5%Positive
ROE18.5%Capital efficiency
Cash$1.73BLiquidity
Debt$194.0MBalance-sheet claim
Forward P/EN/ANo estimate substituted
Intrinsic-value modelN/AFail-closed: insufficient inputs
Value / quality panel3 positive / 1 negative / 1 neutralbullish / confidence 71
Analyst Mean Target$274.44Consensus, not a guarantee

Earnings History

QuarterEPS ActualEPS Est.SurpriseRevenue
3Q2025$4.24$4.29-1.1%-
4Q2025$4.84$5.17-6.3%-
1Q2026$3.22$2.978.3%-
2Q2026$3.92$2.8836.1%-

2/4 captured quarters beat estimates — Next: 2026-10-29T20:00:00Z

Insiders & Institutions

5.4%
Insider Own.
96.9%
Institution Own.

No structured transaction table was captured; aggregate counts are not used.

Capital Structure & Dilution

107.5M
Shares Out.
See filing review
Authorized
low
Dilution Risk

No 2026 equity offering was identified. The 10-Q reports 107.47M shares and only $37.6M of principal debt, so financing dilution is low.

SEC Filings Review

Official filings were reviewed through 2026-08-28; the table lists the decision-relevant documents rather than every routine filing. The C+ grade describes the full dossier; the trade state (wait) is a separate timing decision.

DateFormAccessionWhat the filing changes
2026-07-3010-Q0001274494-26-000170Quantifies Series 7 warranty exposure and the balance sheet.
2026-07-308-K0001274494-26-000169Provides the latest operating update.

Contrarian checks

Short Interest

11.9%
SI % Float
4.87
Days to Cover
N/A
CTB

Current snapshot only; no acceleration claim without a comparable historical series.

Options / Derivatives

10,447
Call OI
4,686
Put OI
2.23
C/P Ratio
$215.00
Max Pain
N/A
IV Mean

Unusual Activity: No unusual activity confirmed

Technical Analysis

RSI (14)42.0
EMA 20$218.40
EMA 50$224.81
EMA 200$225.63
MACD-4.765
Signal-2.839
ATR (14)$10.56
WyckoffTransitional
RSI 42.0 WAIT Wait; trend is damaged
Supports: $187.31 / $196.32 / $176.47
Resistances: $251.62 / $281.02 / $274.97

Technical Setup

Wait; trend is damaged. Required confirmation: Reclaim $213.20 and VWAP. Available moving averages are shown with their provider type.

Performance & Benchmarks

-19.6%
YTD
9.9%
1Y
N/A — insufficient point-in-time history
3Y
Not calculated without aligned benchmark bars.
Alpha

Macro Context

IndicatorValueSignal
Market regimeRisk-on 0.79Trend support, not a timing trigger
VIX14.51Low current protection price

Regime: risk-on

The broad regime supports long setups, but rates and ticker-specific confirmation override the label.

Risk Analysis

Risk Profile: High

Dilution: low; beta: 1.75; insider signal: unavailable.

Trade Structure

High
  • First-target reward/risk at confirmation: 0.84R
  • Wait state: Reclaim $213.20 and VWAP.
Probability
Impact
Reclaim $213.20 and VWAP

Capital and Dilution

Low
  • No 2026 equity offering was identified. The 10-Q reports 107.47M shares and only $37.6M of principal debt, so financing dilution is low.
  • Series 7 defects carry an estimated $40M-$65M loss range.
  • Backlog economics depend on 45X credits and can be reopened; tellurium supply and factory impairment remain material.
Probability
Impact
SEC review: low dilution risk. Filings and accessions are listed below.

Positioning

Low
  • 0 insider buys vs 0 sells
  • Short interest: 11.9%
Probability
Impact
Positioning is context, not a standalone trigger.

Risk Synthesis

A precise stop does not make a setup valid. Entry location, normal volatility, event risk and reachable resistance decide whether the risk is paid.

Social Radar

Stocktwits
30
neutral
35362 watchers; not used as a trigger.
Aggregate sentiment
2
positive
Confidence 23.0%.

Pump & Dump Score: 0/6

Clean
No recent halt flag
Short interest below 20%
SEC-reviewed dilution risk is low

Capital Flow

N/A
Net Flow
N/A
Institutional
N/A
Retail
45.6%
Dark Pool %

No directional flow claim is made when detailed, aligned flow data is unavailable.

Trade Idea

WAIT — Wait state: Reclaim $213.20 and VWAP.
Entry Zone
$209.05
Original zone $208.42-$209.68. Reclaim $213.20 and VWAP. At the conservative $213.20 confirmation price, TP1 pays 0.84R.
Stop Loss
$199.54
-4.84% risk
Target 1
$224.68
7.15% upside
Target 2
$232.08
Stretch target; use the stated TP2 reward/risk below.
Risk/Reward
Confirmation TP1 1:0.84; original plan 1:1.48 / TP2 1:2.21
10 trading sessions

Thesis

Wait; trend is damaged. Monitor reclaim $213.20 and vwap; no market order and no chase outside the zone.

Catalysts

  • Crowded-positioning pressure is flagged, but it is not an entry trigger.
  • Insider activity bearish (0 buys / 26 sells, 90d)
  • The Fly — The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades:

Invalidation

  • Below $199.54
  • Wait state: Reclaim $213.20 and VWAP.
  • Any earnings, clinical, regulatory or financing event before entry requires a fresh review.

Global Score

C+ Technology Neutral

Key Takeaways — Positive

  • Defined trigger: Reclaim $213.20 and VWAP
  • Dilution assessment after filing review: low
  • Revenue growth: -3.7%

Key Takeaways — Risks

  • Wait state: Reclaim $213.20 and VWAP.
  • First-target R/R at confirmation: 0.84R
  • Series 7 defects carry an estimated $40M-$65M loss range.
  • Backlog economics depend on 45X credits and can be reopened; tellurium supply and factory impairment remain material.

Mindset Tip

Wait for confirmation and preserve the invalidation.

Disclaimer

This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.

Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Data comes from point-in-time market snapshots, company filings, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.

Verdict Business News Fundamentals Earnings Insiders Capital SEC Review Technical Perf Risks Social Flow Trade Score